Ilyang Pharmaceutical Co Ltd (007575) — Net Asset Quality Index
Ilyang Pharmaceutical Co Ltd (007575) has a Net Asset Quality Index of 53.8% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩444.81 Billion minus total liabilities of ₩205.41 Billion yields net assets of ₩239.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Ilyang Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ilyang Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2014–2024)
This chart shows how Ilyang Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of June 2025, the index stands at 53.8%, representing net assets of ₩239.41 Billion against total assets of ₩444.81 Billion KRW. See Ilyang Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Ilyang Pharmaceutical Co Ltd (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Ilyang Pharmaceutical Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 007575 market cap.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 56.0% | ₩241.58 Billion | ₩431.21 Billion | ₩189.63 Billion | ▲ +1.0 pp |
| 2023 | 55.1% | ₩196.41 Billion | ₩356.66 Billion | ₩160.25 Billion | ▼ -3.5 pp |
| 2022 | 58.6% | ₩291.85 Billion | ₩498.19 Billion | ₩206.33 Billion | ▲ +3.6 pp |
| 2021 | 55.0% | ₩271.76 Billion | ₩494.27 Billion | ₩222.51 Billion | ▼ -0.8 pp |
| 2020 | 55.8% | ₩244.92 Billion | ₩439.12 Billion | ₩194.19 Billion | ▲ +4.9 pp |
| 2019 | 50.9% | ₩222.74 Billion | ₩437.46 Billion | ₩214.72 Billion | ▲ +2.4 pp |
| 2018 | 48.6% | ₩209.88 Billion | ₩432.25 Billion | ₩222.37 Billion | ▲ +0.2 pp |
| 2017 | 48.3% | ₩210.98 Billion | ₩436.37 Billion | ₩225.39 Billion | ▼ -2.1 pp |
| 2016 | 50.4% | ₩217.35 Billion | ₩431.26 Billion | ₩213.91 Billion | ▲ +1.5 pp |
| 2015 | 48.9% | ₩211.00 Billion | ₩431.63 Billion | ₩220.62 Billion | ▲ +6.3 pp |
| 2014 | 42.6% | ₩183.46 Billion | ₩430.83 Billion | ₩247.37 Billion | — |